Journal of

Clinical Nephrology and Renal CareISSN: 2572-3286


 Open Access DOI:10.23937/2572-3286.1510048

Chronic Kidney Disease in Sickle Cell Disease: Prevalence and Associated Factors in Cameroon

Hermine Danielle Fouda Menye, Gilles Wandji, Francois F Kaze, Denis G Teuwafeu, Yaya Kane, Marie Patrice Halle, Maimouna Mahamat, Hilaire Djantio and Gloria Ashuntantang

Article Type: Original Article | First Published: October 31, 2019

Studies in Cameroon reported high prevalence of urinary abnormalities in sickle cell anemia (SCA). There is a lack of data in this setting on the prevalence of chronic kidney disease (CKD) in SCA and Sickle cell trait (SCT). This was a cross-sectional study of six months durations (April-September 2017) involving SCA (HB SS) and SCT (HBAS) subjects at Douala Laquintinie hospital. CKD was diagnosed and classified according to 2012 Kidney Disease Improving Global Outcomes (KDIGO) criteria. Only pa...

 Open Access DOI:10.23937/2572-3286.1510047

Two Rare Mechanisms for Acute Anuric Renal Failure in a Patient with Metastatic Malignant Melanoma - A Case Report

Amy D Kennedy, MD, Alex J Liu, MD, Regan M Seipp, MD, Margaret S Ryan, MD, Shaun K Yang, MD, MPH and Leslie F Thomas, MD

Article Type: Case Report | First Published: September 27, 2019

This case report examines two rare mechanisms of acute renal failure in a patient with metastatic melanoma treated with high-dose vitamin C. The first is oxalate nephropathy, which is an uncommon but known complication of highdose vitamin C therapy in naturopathic medicine. The second is due to melanuria and renal melanosis, which has been described in metastatic melanoma; however, acute renal failure requiring renal replacement therapy has not been reported previously. We report a patient with ...

 Open Access DOI:10.23937/2572-3286.1510046

Prevalence, Etiology and Clinical Characteristics of Biopsy Proven Non-Diabetic Renal Disease in a Population of 67 Diabetic Patients

Joana Monteiro Dias, Rita Valerio Alves, Mario Gois, Helena Viana and Fernando Nolasco

Article Type: Original Article | First Published: September 25, 2019

Diabetic nephropathy (DN) has been historically the major cause of kidney disease in diabetic patients. However, recent studies have found a high proportion of diabetic patients with biopsy proven Non-diabetic renal disease (NDRD) or NDRD superimposed on DN. These findings have resurfaced the interest in establishing which of these patients may benefit most from a kidney biopsy. Our study aims to enlighten the prevalence and etiology of biopsy proven NDRD and to explore clinical and morphologic ...

 Open Access DOI:10.23937/2572-3286.1510045

Quality of Life in Chronic Hemodialysed Patients: Observational Study in Three Hemodialysis Units in Semi-Urban Areas of Senegal (West Africa)

Kane Yaya, Biao Hermann B, Faye Moustapha, Hamat Ibrahim, Lemrabott A Tall, Faye Maria, Sakho Diama, Camara Mame Selly, Cisse M Moustapha, Seck S Mohamed, Ka El Fary, Niang Abdou and Diouf Boucar

Article Type: Research Article | First Published: August 26, 2019

End-stage renal failure has a significant impact on patients’ daily lives, which can be measured by quality of life questionnaires. The objective of this study was to assess the health condition related to quality of life in hemodialysed patients in three semi-urban hospitals of Senegal and to determine the factors associated with it. During an observational, transversal, descriptive and analytical study conducted for 2 months, between March 1st and April 30th, 2016, the patients’ records, i...

 Open Access DOI:10.23937/2572-3286.1510044

Optimizing Control of Anemia with Ferric Carboxymaltose Administration in Peritoneal Dialysis

JL Merino, MD, PhD, E Garcia, NP, S Castrillo, NP, S Mendoza, NP, V Sanchez, NP, B Bueno, MD, P Dominguez, MD, B Espejo, MD and V Paraiso MD

Article Type: Original Article | First Published: July 12, 2019

Administration of single dose of ferric carboxymaltose (FCM) is useful for both control of anemia in hemodialysis patients and end stage renal disease. Its use in peritoneal dialysis (PD) patients is not as well known. We report our experience of FCM administration in PD patients. PD patients treated with i.v. in the last three years in our unit were analyzed retrospectively. Main reasons for administration of i.v. iron therapy were evaluated. Previously oral iron therapy or erythropoietic stimu...

Volume 5
Issue 2